The gene encoding the natural ligand of murine glucocorticoid-induced tumor necrosis factor receptor (GITR) was cloned and characterized. The putative GITR ligand (GITRL) is composed of 173 amino acids with features resembling those of type II membrane proteins and is 51% identical to the human activation-inducible TNF receptor (AITR) ligand, TL6. Expression of the GITRL is restricted to immature and mature splenic dendritic cells. GITRL binds GITR expressed on HEK 293 cells and triggers NF-kB activation. Functional studies reveal that soluble CD8-GITRL prevents CD4 þ CD25 þ regulatory T-cell-mediated suppressive activities.
Introduction
Members of the tumor necrosis factor superfamily (TNFSF) are involved in the regulation of diverse immune functions. While some members of this family regulate signals leading to apoptosis, others are involved in lymphocyte activation and differentiation. 1 Except for lymphotoxin-alpha, the members of TNFSF are type II membrane proteins 2 and show relatively low sequence conservation (15-34%) within their C-terminal extracellular domains. 3 These molecules bind their respective TNF receptor superfamily (TNFRSF) type I membrane proteins or a soluble form of decoy receptor, which share similar, multiple, cysteine-rich pseudorepeats in their extracellular domains. 4 Glucocorticoid-induced tumor necrosis factor receptor (GITR) is an emerging member of TNFRSF with crucial roles in immune regulation. 5 GITR was initially cloned from a glucocorticoid-treated T-cell hybridoma. Functional analysis demonstrated that GITR-transfected cells were more resistant to anti-CD3-induced apoptosis, compared with untransfected cells, indicating a role for GITR in the control of T-cell activation and death. 6 The promoter region of GITR contains several binding sites responsible for T-cell activation, suggesting that GITR is upregulated in activated T cells. 7 The cytoplasmic region of GITR demonstrates a marked identity with the corresponding region of other TNFRSF members, including CD40, OX-40, 4-1BB, and CD27, pointing to a new subfamily within this superfamily. 8 Recently, GITR has attracted increased attention due to its constitutive expression on the surface of CD4 þ CD25 þ regulatory T cells. 9, 10 Importantly, culture of CD25 þ but not CD25
À T cells with anti-GITR and IL-2 results in a vigorous proliferative response. 9 Thus, anti-GITR is capable of directly inducing a signal in the CD25 þ population that enables the cells to respond to IL-2. This suggests that anti-GITR functions as an agonist for GITR in this assay, providing a signal to the CD25 þ cells, rather than blocking the interaction of GITR with its ligand.
Taken together, these data suggest that engagement of GITR with GITR ligand (GITRL), perhaps expressed on APCs, could produce a signal to control the suppressive function of CD25 þ T cells. Despite mounting evidence in favor of a role for GITR in immunity, efforts to understand the immune regulation mediated by natural interactions between GITR and GITRL have been handicapped by a lack of appropriate reagents and a detailed characterization of GITRL. However, a human homologue of GITR, called activation-inducible TNFR (AITR), has been cloned independently and its ligand (AITRL or TL6) characterized. 8, 11 Although ligation of GITR by anti-GITR mAb (DTA-1), among others, downmodulates regulatory T-cell suppressive activity, 9 it is not clear if soluble GITRL-mediated signaling also contributes to the antisuppressive activity. To better understand GITR-mediated signaling in a more stringent manner, we identified and cloned murine GITRL. The present report is focused on the initial characterization of murine GITRL.
Results
Cloning and sequence analysis of murine GITRL We searched the murine genomic sequence database with TL6, the previously cloned ligand 8 for AITR, a human homologue of murine GITR. A genomic segment with B69% homology was found in murine chromosome 1 near the OX-40 ligand. The sequence, which corresponded to the 3 0 end of the putative GITRL, was used to screen a murine splenocyte cDNA library. A full-length cDNA was cloned and the sequence was determined.
The gene for GITRL spans 9.3 kb and consists of three exons (Figure 1 ). The gene was embedded in a chromosome 1 contig NT-039185, clone RP23 192N9 (Oakland Research Institute, CA, USA). We confirmed that the clone RP23 contained the GITRL gene by Southern analysis (data not shown). GITRL cDNA encodes 173 amino acids with a calculated molecular mass of 20 kDa. The translated GITRL sequence has B51% homology to TL6. It has features of type II membrane proteins and consists of a 21-amino-acid N-terminal cytoplasmic domain, 23-amino-acid transmembrane domain, and 129-amino-acid C-terminal extracellular domain (Figure 1 ).
Characterization and functional analysis of GITRL Successful cloning of GITRL was confirmed using a variety of assays. To test whether the protein product of the cloned GITRL cDNA binds to GITR, in vitro protein binding assay with GST-GITRL fusion protein was performed. In vitro translated, [
35 S]labeled, full-length GITR was incubated with either the GST control or GST-GITRL fusion protein immobilized on glutathione beads. In this assay, [ 35 S]labeled GITR was pulled down only by GST-GITRL fusion protein but not by GST alone. The molecular size of 29 kDa corresponded to the calculated size of unmodified GITR protein (Figure 2a) . We next performed binding assays using flow cytometry. When the GITRL we cloned was transfected into and expressed on HEK 293 cells, GITR-Fc fusion protein detected the GITRL on the cell surface (Figure 2b) . Conversely, expression of transfected GITR on HEK 293 cells was confirmed by DTA-1, a rat monoclonal antibody that binds GITR 9 ( Figure 2c ). The expressed GITR was also detected by soluble GITRL, namely mCD8-GITRL and hCD8-GITRL (Figure 2c ). We further confirmed the specificity of this binding by competition assay using FITC-labeled DTA-1 (anti-GITR mAb) and unlabeled mCD8-GITRL (data not shown). To further ascertain if this binding has a consequence, we next performed functional assays. As shown in Figure 2d , transient expression of full-length GITRL in GITR-expressing HEK 293 EBNA cells readily induced NF-kB activation. Comparable levels of NF-kB activation were also noted when soluble CD8-GITRL fusion protein was expressed in GITR-expressing HEK 293 EBNA cells (Figure 2d ). Interestingly, we noted that mCD8-fused GITRL revealed enhanced binding and stimulation, compared with hCD8-fused protein. To ensure the accuracy of the data, only stable GITR transfectants were used for the NF-kB assays. The level of GITR expression on HEK 293 EBNA cells, as measured by flow cytometry using FITC-labeled DTA-1 mAb, is shown as an inset in Figure 2d . Taken together, these results allow us to conclude that the cloned GITRL reported in this study is a natural ligand for GITR.
Expression of GITRL mRNA
The above results suggested that cloned GITRL specifically binds GITR and activates NF-kB in HEK 293 cells. To further test the expression pattern of this protein on primary cells, we performed RT-PCR analysis. Expression of GITRL mRNA from various lymphoid cell populations is depicted in Figure 3 . While high levels of constitutive expression were observed in splenic dendritic cells, the expression in splenic monocytes and activated peritoneal macrophages was comparatively low. Control experiments showed that the expression pattern of GITRL was comparable to that of 4-1BBL and B7-1, although the levels of B7-1 were much higher than those of either GITRL or 4-1BBL. Notably, expression of GITR and 4-1BB was activation-dependent in CD4 and restricted to dendritic cells under the conditions described.
Regulatory T-cell modulation by GITRL Based on the observation that binding of GITR by GITRL resulted in NF-kB activation, we next proposed to study its effects on T-cell regulation. Previous studies have shown that, among others, the agonistic mAb to GITR, DTA-1, abrogates in vitro CD4 þ CD25 þ regulatory T-cell-mediated suppression when added to a co-culture of CD4 þ CD25 þ and CD4 þ CD25 À T cells. 9 Since soluble GITRL binds GITR and relays activation signals to responding cells, we examined whether the CD8-GITRL fusion protein produced activities similar to those exhibited by DTA-1 mAb. As shown in Figure 4 , addition of GITRL fusion protein inhibited the suppressive activities of CD4 þ CD25 þ regulatory T cells. Interestingly, the mCD8-fused GITRL emerged as a better agonist than hCD8-fused GITRL, thus corroborating our binding analysis data (Figure 2d ). Increasing the mCD8-GITRL concentration (25 mg/ml) led to nearly complete elimination of the suppressive activity of CD4 þ CD25 þ regulatory T cells. Collectively, these data indicate that GITRL can participate in controlling the activities of CD4 þ CD25 þ regulatory T cells.
Discussion
To date, studies aimed at understanding GITR-mediated immune regulation have utilized signaling with mAbs, because information on the natural ligand and the possible effects of GITR-GITRL interactions have not been available. In the present report, we provide the identification, cloning, and initial characterization of murine GITRL, the natural ligand of GITR. GITRL was cloned by searching the murine genomic database with human TL6 as a template sequence. Detection of this sequence has remained elusive for a number of years even though the mouse form is highly homologous to the human sequence (B69% at exon III). The difficulty in cloning the cDNA sequence may have been due, in part, to a low level of expression and limited distribution, in that only dendritic cells and monocytes express the RNA. 
cells (24 h), splenic monocytes, peritoneal macrophages, immature dendritic cells (DC) (0 h), mature dendritic cells (36 h), and naïve CD4
þ CD25 þ T cells (0 h). Each gene was amplified using specific primer sets, and the PCR products were analyzed by 1.5% agarose gel electrophoresis.
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A ligand for human GITR (TL6) has been identified in two independent studies, 8, 11 one of which 8 showed that TL6 was not expressed by unstimulated or stimulated T or B cells, but was constitutively expressed in umbilical vein endothelial cells. This finding underscores the fact that GITR/GITRL interactions are important in the interaction of lymphocytes with the vascular endothelium. However, it is possible that murine GITRL is expressed on other cell types, including subpopulations of APCs or responder T cells. Our present study demonstrates that, as with TL6, GITRL transcripts are not detected on T cells (CD4 and CD8) in the mouse system. On the other hand, naïve as well as activated splenic dendritic cells produced GITRL message. The significance of exclusive expression of GITRL on dendritic cells is unclear, but it suggests that GITR-GITRL interactions between T cells and dendritic cells (T-DC) may play a role in this pathway. This would be particularly important for regulatory T-cell function, in that GITRL expression during an ongoing inflammatory response to a pathogen may be necessary to regulate the suppressive activity of CD4 þ CD25 þ T cells under conditions requiring a stringent effector immune response.
One of the important features of GITR-mediated signaling is the suppressive effect it has on regulatory T cells in in vitro cultures. This has been elegantly demonstrated in several studies utilizing antibodies to GITR (DTA-1). 9 Our present study further substantiates this notion, in that addition of soluble GITRL led to desuppression of CD4 þ T cells. Additionally, the ability of soluble GITR to support NF-kB activation provides strong support for the idea that natural interactions between GITR and GITRL, presumably in T-DC, can regulate immune responses. The fact that GITR is constitutively expressed on regulatory T cells and GITRL on dendritic cells suggests that control of CD4 þ CD25 þ T cells must be by GITRL. However, it remains to be determined whether GITRL provides CD4 þ CD25 þ regulatory T cells with a desuppressive signal in vivo as it does in vitro. Since information on GITRL is now available, investigation of the modulation of CD4 þ CD25 þ T cells through GITR-GITRL interaction in vivo can now be undertaken. Such studies are important, particularly as regulation of GITRL expression during inflammation and patterns of GITRL expression could hold the key to our understanding of CD4 þ CD25 þ regulatory T-cell modulation through GITR.
Materials and methods

cDNA cloning
The nucleotide sequence of human TL6 was used to search the database of the mouse genome. A murine genomic region containing a sequence B69% homologous to TL6 was identified and used to screen a cDNA library from activated murine splenocytes. The complete cDNA sequences of both strands of the clone were determined and the homology to TL6 determined.
Expression plasmids
Full-length GITRL cDNA was cloned in a pCR3.1 expression vector (InVitrogen, Carlsbad, CA, USA). Flag-tagged GITRL was produced by PCR using a sense (5 0 -GGATCCAGCGCGCCATGGAGGAATGCCTT TGAGAG-3 0 ) and an antisense (5 0 -GCTCTAGACTATTC GTCCTTGTAGTCAGAGATGAATGGTAGATCAGG-3 0 ) primer and inserted into a pCR3.1 vector. CD8-GITRL fusion genes were produced by PCR, employing the extracellular domain of human (h) or murine (m) CD8 at the N-terminus and murine GITRL at the C-terminus, and inserted into a pCR3.1 vector. The extracellular domain of hCD8 was amplified by RT-PCR using human CD8 þ T lymphocyte RNA with a sense (5 0 -GGATCCAGCGCGCCATGGCCTTACCAG TGA-3 0 ) and an antisense (5 0 -CTCGATGACAGTTGGC TTGGCGAAGTCCAGCCCCCT-3 0 ) primer. The extracellular domain of mCD8 was amplified by RT-PCR using murine splenocyte RNA with a sense (5 0 -GGATC CGCACACCATGGCCTCACCGTTG-3 0 ) and an antisense (5 0 -CTCGATGACAGTTGGCTTGTCCAATCCG GTCCCCTT-3 0 ) primer. The extracellular domain of GITRL was amplified by PCR with a sense (5 0 -AGGG GGCTGGACTTCGCCAAGCCAACTGTCATC GAG-3 0 ) and an antisense (5 0 -GCTCTAGACTAAGAGATGAAT GGTAG-3 0 ) primer.
RT-PCR primer sequences GITRL mRNA expression was determined by RT-PCR in various lymphoid cell subpopulations, and compared with the mRNA expression of GITR, 4-1BB, CD28, B7-1, and 4-1BBL. The sense and antisense primers used for PCR were as follows:
) were cultured alone or with 1 Â 10 5 CD4 þ CD25 þ T cells for 3 days. Anti-GITR-mAb (DTA-1) was used as a positive control to neutralize the suppressive activity of CD4 þ CD25 þ regulatory T cells. Rat IgG was used as a negative control. Purified soluble mCD8-GITRL or hCD8-GITRL was added at a concentration of 2.5 or 25 mg/ml. Cells were labeled with [
Recombinant proteins
Recombinants for hCD8-GITRL and mCD8-GITRL fusion proteins were produced in transiently transfected HEK 293 cells. Secreted CD8-GITRL fusion proteins were purified from the culture supernatant by affinity chromatography with Affi-gel 10 (Bio-Rad, Hercules, CA, USA) crosslinked with either anti-hCD8a mAb (Ancell, Bayport, MN, USA) or anti-mCD8a mAb (eBioscience, San Diego, CA, USA). GITR-Fc fusion protein was obtained from KOMED (Seoul, Korea). GST-GITRL fusion protein was produced in E. coli strain BL21 and purified according to the manufacturer's protocol (Novagen, Madison, WI, USA).
Cell lines GITR-expressing HEK 293 EBNA cells were produced by transfecting full-length GITR in a pCEP4 vector, and selected for hygromycin resistance. GITRL-expressing HEK 293 cells were prepared by transfecting full-length GITRL in a pCR3.1 vector, and selected for G418 resistance.
Binding assays
To determine the binding of GITRL to GITR on the cell surface, GITR-transfected HEK 293 EBNA cells were incubated with anti-GITR mAb (DTA-1, a kind gift from Dr Shimon Sakaguchi, Kyoto University, Japan) or CD8-GITRL and FITC-anti-CD8 mAb. Flow cytometry was performed with the Becton Dickinson FACS s Calibur (San Jose, CA, USA). GITRL-transfected HEK 293 cells were stained with GITR-Fc and FITC-anti-Fc mAb (PharMingen) and analyzed by FACS. For in vitro protein binding assays, 1 mg of Xho I-digested pCR3.1-GITR was used for in vitro translation. GITR was labeled with [ 35 S]methionine (B1 mCi/mmol, Amersham, Piscataway, NJ, USA) using the TNT-coupled reticulocyte lysate (Promega, Madison, WI, USA). Binding assays were performed as described previously. 12 Analysis of NF-jB activity by luciferase assay GITR-expressing HEK 293 EBNA cells (0.5 Â 10 6 cells/ well) were transfected with pCR3.1-GITRL, pCR3.1-mCD8-GITRL, or pCR3.1-hCD8-GITRL, as well as the NF-kB-dependent E-selectin-luciferase reporter plasmid (pELAM-luc) and pRSV-b-galactosidase (pRSV-b-gal). 13, 14 The total amount of plasmid was adjusted to 2.0 mg by adding empty vector. Cells were lysed in 200 ml of reporter lysis buffer (Promega, Madison, WI, USA) at 0, 24, and 48 h after transfection. Luciferase activity was measured using 20 ml of cell extract. In total, 5 ml of cell extract was used to assay b-gal activity as an internal control, and luminescence values were normalized by individual b-gal activity. þ CD25 À T cells were 496% pure. To prepare immature splenic dendritic cells, spleens were digested with 1.7 mg/ml collagenase type IV (Sigma, St Louis, MO, USA) and 1 mg/ml DNase I (Sigma) in IMDM (InVitrogen) for 45 min at 371C. The cells were washed once, and CD11c-expressing cells were enriched using biotinylated anti-CD11c-mAb, streptavidin-conjugated magnetic beads, and MidiMACS columns (Mitenyi Biotec) following the manufacturer's protocol. Mature splenic dendritic cells were isolated from splenocytes cultured with 5 mg/ml of LPS (Sigma) for 36 h. Splenic monocytes were prepared by harvesting cells adherent to plastic tissue culture dishes. Peritoneal macrophages were induced by injection of 3 ml of 1% thioglycollate (Difco Laboratories, Detroit, MI, USA) in PBS. Macrophages were harvested by peritoneal lavage with ice-cold modified HBSS on day 4. Cells were sedimented by centrifugation at 150 Â g for 10 min at 41C, resuspended in RPMI-1640 medium, and counted, after which cell concentrations were adjusted for plating. Cells were cultured for 1 h at 371C and nonadherent cells were removed. Adherent cells were cultured for another 17 h and nonadherent cells were discarded to remove dendritic cells and B cells. The remaining cells (adherent cells) were used as activated peritoneal macrophages.
Proliferation assays CD4
þ CD25 À T cells (2 Â 10 5 cells/well) and g-irradiated splenocytes (2 Â 10 4 cells/well) as APCs were cultured with or without CD4 þ CD25 þ regulatory T cells (2 Â 10 5 cells/well) in 96-well, round-bottom plates (Costar, Cambridge, MA, USA) in DMEM (InVitrogen) with 10% FBS and antibiotics. Anti-CD3 (145.2C11) (0.5 mg/ ml) and either DTA-1 (5 mg/ml), mCD8-GITRL (2.5 or 25 mg/ml), or hCD8-GITRL (2.5 or 25 mg/ml) were also added to each well. The mixture was incubated for 72 h at 371C and labeled with 1 mCi of [ 
